BrezaMSmyrniNKoutsisGet al. Ocular flutter as presenting manifestation of pediatric MOG antibody–associated demyelination: A case report. Mult Scler2019; 25: 122–125.
2.
SaMThorntonRKling ChongWKKaliakatsosMHacohenY.Paediatric MOG antibody–associated ADEM with complex movement disorder: A case report. Mult Scler2019; 25: 125–128.
3.
RamanathanSMohammadSTantsisEet al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry2018; 89: 127–137.
4.
Cobo-CalvoARuizAMaillartEet al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology2018; 90: e1858–e1869.
5.
JariusSRuprechtKKleiterIet al. MOG-IgG in NMO and related disorders: A multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation2016; 13: 280.
6.
JurynczykMMessinaSWoodhallMRet al. Clinical presentation and prognosis in MOG-antibody disease: A UK study. Brain2017; 140: 3128–3138.